- Journalists Discuss Healthcare Costs’ Political Fallout, Concerns About Canceled ICE Facility
- Missouri hospital names interim chief administrative officer
- OSF taps foundation president
- Morgan Medical Center launches cardiology service line in Georgia
- The hospitals, health systems cutting jobs in 2026
- Nevada expands Medicaid dental benefits for adults
- 2 dead in Missouri hospital shooting
- New Mexico dentist fined $320K for violating Controlled Substances Act
- Ketamine: 5 notes for behavioral health leaders
- 60 statistics on hospital expenses in mid-2026
- Judge dismisses Stryker cyberattack lawsuit; plaintiffs could refile
- 42 hospitals closing departments or ending services
- Oklahoma surgeon completes world’s 1st knee procedures with Lantern ASC system
- The colonoscopy reimbursement cut GI ASCs didn’t see coming
- Aspen Dental to open Alabama office
- Anthropic’s biggest healthcare bets: 6 key moves
- Mental health admissions averaged $15.9K in total costs: 5 things to know
- DSOs target de novo practices: 7 updates
- 50+ dental executives on the move in the 1st half of 2026
- Gender ratio of nurse practitioners across 50 states
- Palomar Health, UC San Diego Health finalize JPA, form new system
- 6 DSOs making headlines
- 7 new psychiatric residency programs to know
- The ASC cost crisis, by specialty
- US Heart and Vascular expands network with 2 cardiology practice partnerships
- The states losing anesthesiology residents fastest
- 5 mergers, acquisitions in June
- South Carolina behavioral health agency cuts 47 filled positions
- U of Rochester Medical center taps GI surgery chief
- DEA moves to schedule synthetic kratom compound
- The newest weapon against insurer nonpayment — and its growing controversy
- CMS wants power to remove ‘problematic’ physicians, ASCs from Medicare
- Physician practice owner to pay $1.5M to resolve false claims allegations
- 5 DSOs that dominated Q2
- FDA Lets 20 ZYN Nicotine Pouches Claim Lower Risk Than Cigarettes; Critics Warn Of Danger
- Ultra-Processed Foods Linked To Brain Differences In Young Children
- Prompt Responses From Mom Might Lower A Baby's Risk Of Childhood Mental Health Problems
- Rehab Program Helps Lift Long COVID 'Brain Fog'
- Why Are You Right- Or Left-Handed? Experiments Suggest Surprisingly Simple Explanation
- Rural Americans More Likely To View Cancer As A Death Sentence, Poll Finds
- He Dreamed Of Becoming A Physician Assistant. New Loan Rules May Thwart Him.
- New Disease Threats Follow Trump Administration’s Health Program Cuts
- HealthQ Special: Caregiving in the Sandwich Generation
- A Mom Said Infant Formula Killed Her Baby. The Manufacturer Closed the File.
- Author Health expands mental health, dementia care services
- PDS Health opened 5 de novo offices in June
- Heartland Dental added 6 de novo offices in June
- California’s school behavioral health reimbursement program stalls
- CMS mulls tougher Medicare enrollment rules to combat fraud as part of 2027 home health payment rule
- Tenpoint debuts cast of lively everyday objects to zoom in on blurry vision hassles in Yuvezzi ad
- CMS goes live with GLP-1 Bridge program for Part D beneficiaries
- New Connecticut law expands Yale psychedelic-assisted therapy pilot
- The missing piece in crisis care? A model that avoided 1,580 ED days
- FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel
- Lonza expands partnership with US drugmaker, boosts capacity for ADCs
- Trump administration withholds funds from New York's Medicaid fraud unit
- Alcohol accounts for 74% of substance use inpatient stays: 4 things to know
- Sanofi unit in Ireland chided by FDA over manufacturing flubs linked to Altuviiio
- Regulatory tracker: FDA sets decision date for Sarepta's DMD drugs
- Can A Popular Muscle Supplement Help Treat Depression?
- Zelis rolls out AI solution to help payers navigate No Surprises Act dispute process
- BridgeBio attracts $1B in equity for new launches, but analyst smells M&A ‘dry powder’
- Melatonin Shows Promise As Safe, Cheap Painkiller, Review Concludes
- Heat Dome Coming: Tips To Stay Safe During Extreme Temps
- Diets That Lower Inflammation Might Cut Dementia Risk, Study Indicates
- Vitamins Might Be Key To Asthma Control In Children, Adults
- Kimball lays out $103M to bolster life sciences CDMO footprint across Europe, India
- Haleon teams up with Microsoft in 5-year AI pact to upgrade consumer health operations
- ACCESS Model: behavioral health edition
- Would Hunters Take A Lyme Disease Vaccine? We Asked
- Affordable Healthcare Emerges as a Voter Priority in Purple Nevada
- Newsom Vowed To Transform Kids’ Mental Health. Many California Schools Are Still Waiting.
- Plus Therapeutics rebrands as Cerenome as it deepens AI strategy
- Orca Bio makes a splash with FDA approval for cell therapy Tregzi. Could an IPO come next?
- Remarks at the Economic Club of New York
- Evernorth unveils new AI-powered specialty pharmacy program, Pharmacy Forward
- 26 states sue CMS over final Medicaid work requirements rule
- Startup Queue lands $12.6M to launch autonomous robotic pharmacy kiosks
- Carbon Health agrees to revise contracts with its California clinics, pay penalties
- Experity acquires Exdion Healthcare to accelerate on-demand care RCM automation
- AstraZeneca agrees to pay $34M to settle 'free nurses' kickback lawsuit from Texas
- From Caffeine To 'Healthy' Labeling, FDA Sets Year-End Agenda For US Food Supply
- A 40-Year-Old Law Requires ERs To Treat Everyone — Unless They Opt Out
- Major Study Supports Same-Day COVID-19 and Flu Vaccination
- American Hospital Association names Steve Walsh as next CEO
- Medical journal retracts Tavneos pivotal study article, complicating Amgen’s defense effort
- Hyro rolls out analytics platform to glean insights from AI agent interactions
- Women With Parkinson's More Likely To Have Brain Changes Related To Alzheimer's
- Even Mild Weather Changes Impact Mental Health
- Breastfeeding Might Lower ADHD Risk, Study Finds
- After monotherapy failure, AbbVie and Genmab tout Epkinly combo win in DLBCL
- FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program
- She Struggled To Get A Lifesaving Drug Even After Insurers Vowed To Help
- Trouble Getting Weight Loss Drugs Covered By Insurance? Here's What To Know
- Would Hunters Take a Lyme Disease Vaccine? We Asked
- These Church Members Disagree on Politics. Together They’re Wiping Out Medical Debt.
- He Dreamed of Becoming a Physician Assistant. New Loan Rules May Thwart Him.
- Unicycive turned away by FDA again over manufacturer’s plant shortfalls
- Roche tops oncology reputation rankings as AstraZeneca climbs back to 2nd place
- Rising Stars: How Novo Nordisk’s Tara Sparks Went from Super Bowl Fan to Super Bowl Marketer
- Rural residents falling behind urban and suburban communities on medical, cancer screenings
- CMI Media Group bridges gaps in pharma marketing tech with newly launched Ad Astra platform
- How payers, drugmakers can collaborate to drive more outcomes-based contracts
- BeOne’s Brukinsa hits goal in mantle cell lymphoma confirmatory trial
- HRSA opens applications for $140M in rural health grant funding
- ACA marketplace enrollment down by 3M as of February, new federal data show
- Cases Of Rare But Dangerous Powassan Tick Virus Rising In U.S.
- Nearly 3 in 10 Young Adults Don't Have a Regular Doctor, Survey Finds
- Clinic network CEO pleads guilty to embezzling millions for 'social media influenced' market trading
- AI playing a major role in consumers' healthcare decision-making, survey finds
- Zymeworks acquires struggling Theravance for $929M
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- Klick bags Oxford PharmaGenesis in 3rd takeover in 18 months
- FDA rejects Sobi’s gout drug over manufacturing issues, sparing Amgen blockbuster
- Fertility Preservation Often Overlooked In Women's Cancer Care, Review Finds
- Sedatives Pose Fall Hazard For Recently Hospitalized Seniors
- Fourth Of July Poses Burn Hazards — Here's How To Protect Kids
- Efforts To End School Vaccine Mandates Hit A Wall In Florida
- A Dog's Stride Could Be An Early Sign Of Dementia, Study Says
- Florida Hospitals Act Fast To Discharge Gun Victims — Especially if They’re Not Insured
- Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa
- Doctronic, Simple HealthKit partner to connect at-home screening with AI-powered clinical care
- HHS announces new oversight measures for TEFCA, touts 1B health records exchanged
- Cancer Drug Shortage Renews Calls For Federal Action
- 3 in 10 adults turn to AI or social media for health advice, citing difficulties accessing and affording care
- Next-Generation Blood Test Improves Detection Of Aggressive Prostate Cancer
- Saint Peter’s Healthcare System Expands Intelligent Hospital Room Initiative with hellocare.ai to Advance AI Assisted Patient Safety and Virtual Care
- As PBM industry shifts, LucyRx and Abarca Health merge to build scale
- One Brooklyn Health Selects hellocare.ai to Advance AI-Powered Virtual Care Across Its Hospitals
- Most Patients Want Docs To Break Cancer News Directly, Not Through Portal Messaging
- Statins Rarely Cause Severe Muscle Problems, Researchers Say
- Even In Blue States, Hospitals Continue To Drop Gender-Affirming Care For Youths
- Younger U.S. Generations Increasingly Fear Adulthood, Study Says
- Opioid Settlement Money Pays For Services To Battle Addiction In Rural Kentucky
- Air Force Outbreak Grows As Military Reinstates Flu-Shot Rule For Recruits
- GLP-1 Weight-Loss Boom Linked To Surge In Poison Control Calls
- Brain Scans Improve Targeting Of Magnetic Stimulation For Depression
- Estrogen Birth Control May Protect Women’s Brains As They Age
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
Michigan healthcare freedom community forum
National Institutes of Health (NIH) Director Jay Bhattacharya was on the receiving end of a diversity, equity and inclusion (DEI) firestorm during the COVID panic. He firmly believes the scientific approach to turn discoveries into better health has been corrupted by a new mission and ideology: diversity, equity and inclusion (DEI).
Here is his action plan:
https://thespectator.com/topic/cured-dei-national-institutes-health-jay-bhattacharya-matthew-memoli/
How we cured DEI at the National Institutes of Health
Scientists no longer have to mouth DEI shibboleths to garner funding
By Jay Bhattacharya and Matthew J. Memoli - December 11, 2025Since the National Institutes of Health was founded as a one room laboratory in 1887 its mission was simple; perform biomedical research to enhance health, lengthen life and reduce illness and disability for Americans. Scientists for more than one hundred years have taken this scientific approach to turn discoveries into better health. This mission unites all Americans of every race, color and creed. Everyone wants science that benefits their health.
Over the last decade and a half this mission has been corrupted by a new mission and ideology: diversity, equity and inclusion (DEI). This political ideology was reflected in all aspects of the NIH, including hiring practices, promotion and tenure, employee training, performance reviews, communications, management and, yes, even science.
For its entire history NIH funding decisions were made to reach scientific goals. DEI drove decisions to be made to reach political goals instead, requiring NIH scientists to write DEI statements – de facto loyalty oaths – and researchers outside the NIH applying for grants to write plans for enhancing “diverse perspectives” (another name for a DEI statement). Scientific reviewers were chosen based on DEI criteria, and those making funding decisions received bonuses for promoting DEI.
At the end of every fiscal year, NIH program officers handed out “diversity supplements” to universities, directing money to training programs based partly on scientists’ race, rather than their scientific ability. In 2022, the NIH announced funding for universities to conduct “system-wide” DEI audits to address “shortcomings” in addressing “structural racism.”
Scientists learned that the best way to maximize their chance of a slice of NIH money was to promise that their work would help achieve racial nirvana, however remote from utopian ideological pursuits the proposed work actually was. Most scientists obsequiously complied to avoid the risk of career harm, whether they were true believers or not.
NIH policy was fundamental in the DEI-ification of the nation’s top universities and research centers. Even before the fevered days of 2020, when the mania for DEI at universities reached a fever pitch, scientists were often required to write DEI loyalty oaths to be hired or promoted.
In 2020, at Stanford University, radical students circulated a blacklist of professors they considered guilty of wrongthink and harassed them for their ideological impurity. The administration published an “elimination of harmful language” banned word list, creating a hostile work environment for those whose beliefs fell outside the bounds of orthodox DEI-ism. All of this occurred with the approval and even applause of university leaders. Stanford was not alone; top universities embraced similar policies.
None of this reorientation of the NIH and the universities toward DEI translated into improving the health status of Americans. Between 2011 and 2019, life expectancies of nearly every racial group in the US flatlined. All Americans shared in the expanding chronic disease crisis that has made America among the least healthy economically developed nations on earth. Chronic disease does not discriminate and DEI is not the solution.
NIH’s devotion to DEI ended when President Trump took office in January 2025. At the NIH, we dismantled the DEI apparatus and refocused the NIH on its age-old mission. We oversaw a large-scale effort by all parts of NIH to eliminate DEI from its processes, including eliminating loyalty oaths and other DEI statements, removing DEI from performance reviews, hiring and promotion, and purging DEI from all facets of scientific review, notices of funding opportunity (NOFO) and grant decision making.
Though activist courts have restricted our ability to excise many DEI-focused grants from our portfolio, NIH has now terminated hundreds of NOFOs and modified the terms of more than 6,000 grants that contain unscientific DEI-related statements, projects and methods. Because DEI was so deeply embedded in the NIH’s portfolio, it will take some time to complete the work, but by the end of this fiscal year, we will have restored merit and science-based research to their rightful place at the NIH.
We continue to enthusiastically support research that advances the health of all Americans, regardless of their age, race, ethnicity, sex, sexual orientation, or other characteristics. We will unapologetically invest in rigorous science – research that genuinely improves the health of minority populations, rather than serving political ideologies that misuse taxpayer resources.
The NIH will not fund research based on ideologies that promote differential treatment of people based on race or ethnicity, nor will we fund studies exploring broad, poorly defined concepts such as racial microaggressions or implicit bias. Such work diverts resources away from projects that advance the health and longevity of all Americans, including minority populations.
So that the NIH never again strays from its mission, we have established new formal priorities for the NIH, with DEI removed and gold standard science leading the way. Scientists will no longer have to mouth DEI shibboleths to garner funding but instead propose excellent science that helps make America healthy again.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






















